Truist Securities Maintains Hold on Medtronic, Lowers Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter maintains a Hold rating on Medtronic (NYSE:MDT) and lowers the price target from $93 to $90.
May 26, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities maintains a Hold rating on Medtronic and lowers the price target from $93 to $90.
The news directly mentions Medtronic (NYSE:MDT) and the lowered price target by Truist Securities. This may cause some investors to reconsider their positions, but the Hold rating suggests that the overall outlook remains neutral. The lowered price target may have a limited short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100